Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Fuji
Boehringer Ingelheim
US Army
Chinese Patent Office
Mallinckrodt
QuintilesIMS
Farmers Insurance
Harvard Business School

Generated: October 21, 2017

DrugPatentWatch Database Preview

TICLID Drug Profile

« Back to Dashboard

What is the patent landscape for Ticlid, and when can generic versions of Ticlid launch?

Ticlid is a drug marketed by Roche Palo and is included in one NDA.

The generic ingredient in TICLID is ticlopidine hydrochloride. There are nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ticlopidine hydrochloride profile page.

Summary for Tradename: TICLID

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list97
Clinical Trials: see list1
Patent Applications: see list1,570
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TICLID at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-001Mar 24, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-002Oct 31, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TICLID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-001Mar 24, 1993► Subscribe► Subscribe
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-002Oct 31, 1991► Subscribe► Subscribe
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-002Oct 31, 1991► Subscribe► Subscribe
Roche Palo
TICLID
ticlopidine hydrochloride
TABLET;ORAL019979-001Mar 24, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Healthtrust
Baxter
US Army
Fish and Richardson
US Department of Justice
Moodys
Medtronic
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot